Mortality in atrial fibrillation
Event: EHRA 2019
Topic: Pathophysiology and Mechanisms
Session: Unanswered but key aspects in atrial fibrillation
Symptomatic atrial fibrillation in the elderly - Atrioventricular node ablation is an attractive strategy - CONTRA
Event: EHRA 2019
Topic: Treatment
Session: Knowledge gaps in clinical atrial fibrillation
LGE-MRI atrial fibrosis predicts 5 year outcome of atrial fibrillation ablation
Event: EHRA EUROPACE - CARDIOSTIM 2017
Topic: Catheter ablation (Atrial Fibrillation)
Session: Rapid Fire session 4 - Catheter ablation of atrial fibrillation: Predictors and outcome
Anticoagulant should be prescribed for Atrial fibrillation in stage IV-V kidney disease.
Event: EHRA EUROPACE - CARDIOSTIM 2017
Topic: Anticoagulation
Session: Anticoagulation for non-valvular atrial fibrillation in 2017
Assessment of pulse wave pressure changes for detection of arrhythmia and comorbidities using a wrist-worn wearable device
Event: EHRA EUROPACE - CARDIOSTIM 2017
Topic: Clinical and epidemiological aspects (Atrial Fibrillation)
Session: Atrial Fibrillation - Clinical and epidemiological aspects
ESC 365 is supported by
